iRhythm Technologies, Inc. (NASDAQ:IRTC) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET
Company Participants
Stephanie Zhadkevich - Director of Investor Relations
Quentin Blackford - President and Chief Executive Officer
Doug Devine - Chief Operating Officer and Chief Financial Officer
Dan Wilson - EVP of Corporate Strategy and Development
Conference Call Participants
Calvin Chu - Morgan Stanley
Allen Gong - JPMorgan
Joanne Wuensch - Citi
Brandon Vazquez - William Blair
David Rescott - Truist Securities
Marie Thibault - BTIG
Bill Plovanic - Canaccord
Suraj Kalia - Oppenheimer
Michael Polark - Wolfe Research
Operator
Good afternoon, everybody, and welcome to today's iRhythm Technologies, Inc. Q2 2022 Earnings Conference Call. My name is Drew, and I'll be coordinating your call today. [Operator Instructions]
I'm now going to hand over to Stephanie Zhadkevich, Director of Investor Relations, to begin. Please go ahead.
Stephanie Zhadkevich
Thank you all for participating in today's call. Earlier today, iRhythm released financial results for the second quarter ended June 30, 2022.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements. These are based upon our current estimates and various assumptions and reflect management's intentions, beliefs and expectations about future events, strategies, competition, products, operating plans and performance. These statements involve risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.
Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our most recent annual and quarterly reports on Form 10-K and Form 10-Q, respectively, filed with the Securities and Exchange Commission.
Also during the call, we will discuss certain financial measures that have not been prepared in accordance with U.S. GAAP with respect to our non-GAAP and cash-based results, including adjusted EBITDA, adjusted operating expenses and adjusted net loss. Unless otherwise noted, all references to financial metrics are presented on a non-GAAP basis. The presentation of this additional information should not be considered in isolation of as a substitute for or superior to results prepared in accordance with GAAP. Please refer to the tables in our earnings release and 10-Q for a reconciliation of these measures to the most directly comparable GAAP financial measures.